These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 886843)

  • 21. Steroid enhancement of Mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1982 Oct; 17(5):453-8. PubMed ID: 6897422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Müllerian inhibiting substance in sex-reversed dogs.
    Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
    Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
    Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
    N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation of production of anti-müllerian hormone by the fetal gonad.
    Josso N; Vigier B; Tran D; Picard JY
    Arch Anat Microsc Morphol Exp; 1985; 74(1):96-100. PubMed ID: 3840970
    [No Abstract]   [Full Text] [Related]  

  • 25. Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance.
    Donahoe PK; Krane I; Bogdén AE; Kamagata S; Budzik GP
    J Pediatr Surg; 1984 Dec; 19(6):863-9. PubMed ID: 6084056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Precocious production of müllerian inhibitor by the fetal rabbit testis].
    Koike S; Jost A
    C R Seances Acad Sci III; 1982 Dec; 295(12):701-5. PubMed ID: 6820303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Müllerian hormone in three intersex conditions.
    Harbison MD; Magid ML; Josso N; Mininberg DT; New MI
    Ann Genet; 1991; 34(3-4):226-32. PubMed ID: 1809231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody to Mullerian inhibiting substance.
    Mudgett-Hunter M; Budzik GP; Sullivan M; Donahoe PK
    J Immunol; 1982 Mar; 128(3):1327-33. PubMed ID: 6895760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of the testicular mullerian-inhibiting hormone on ovarian development in the chick embryo].
    Stoll R; Rashedi M; Maraud R
    C R Seances Soc Biol Fil; 1975; 169(4):927-30. PubMed ID: 129264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of müllerian inhibiting substance in preterm and term male neonates.
    Schwindt B; Doyle LW; Hutson JM
    J Urol; 1997 Aug; 158(2):610-2. PubMed ID: 9224378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mullerian inhibiting substance binding and uptake.
    Catlin EA; Ezzell RM; Donahoe PK; Manganaro TF; Ebb RG; MacLaughlin DT
    Dev Dyn; 1992 Apr; 193(4):295-9. PubMed ID: 1511169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced purification of Mullerian inhibiting substance by lectin affinity chromatography.
    Budzik GP; Swann DA; Hayashi A; Donahoe PK
    Cell; 1980 Oct; 21(3):909-15. PubMed ID: 6893682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum müllerian inhibiting substance assay--a new diagnostic test for disorders of gonadal development.
    Forest MG
    N Engl J Med; 1997 May; 336(21):1519-21. PubMed ID: 9154774
    [No Abstract]   [Full Text] [Related]  

  • 34. Delay of testicular differentiation in the B6.YDOM ovotestis demonstrated by immunocytochemical staining for müllerian inhibiting substance.
    Taketo T; Saeed J; Nishioka Y; Donahoe PK
    Dev Biol; 1991 Aug; 146(2):386-95. PubMed ID: 1713865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mullerian inhibiting substance in the ovary.
    Donahoe PK; Takahashi M; Ueno S; Manganaro TF
    Prog Clin Biol Res; 1988; 267():153-75. PubMed ID: 3070561
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.
    Lane AH; Lee MM; Fuller AF; Kehas DJ; Donahoe PK; MacLaughlin DT
    Gynecol Oncol; 1999 Apr; 73(1):51-5. PubMed ID: 10094880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular descent--a proposed interaction between müllerian inhibiting substance and epidermal growth factor.
    Siow Y; Fallat ME
    J Urol; 1997 Aug; 158(2):613-4. PubMed ID: 9224379
    [No Abstract]   [Full Text] [Related]  

  • 38. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity.
    Shima H; Donahoe PK; Budzik GP; Kamagata S; Hudson P; Mudgett-Hunter M
    Hybridoma; 1984; 3(3):201-14. PubMed ID: 6548727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The critical period for mullerian duct regression in the dog embryo.
    Meyers-Wallen VN; Manganaro TF; Kuroda T; Concannon PW; MacLaughlin DT; Donahoe PK
    Biol Reprod; 1991 Oct; 45(4):626-33. PubMed ID: 1751638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Müllerian inhibiting substance.
    Bashir MS; Wells M
    J Pathol; 1995 Jun; 176(2):109-10. PubMed ID: 7636619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.